CQ Weekly (6/8, Zeller) reports that after the nine leading U.S. drug manufacturers took out Google ads, the FDA wrote to them all advising them that “sponsored links they’d paid for on Google violated the agency’s drug-advertising protocols. The short promotional items with a link to a Web address providing more information appear on Google when a Web surfer searches for ailments treated by the medication. The FDA said that although they promoted a drug’s efficacy at combating disease, they failed ‘to communicate any risk information associated with the use of these drugs.’
From the American Association for Justice news release
